Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15( d )15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 20182019

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15( d )15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to _____________

 

Commission file number: 001-09043

 

MedAmerica Properties Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

36-3361229

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

Boca Center, Tower 1, 5200 Town Center Circle, Suite 550, Boca Raton, Florida 33486

(Address of principal executive offices) (Zip Code)

 

561-617-8050

(Registrant’s

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

(Former name, former address and former fiscal year, if changed since last report)None

N/A

N/A

 

Indicate by a check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by a check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ☐

Accelerated filer   ☐

Non-accelerated filer   ☐ 

Smaller reporting company   ☒

 

Emerging growth company   ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of November 2, 2018,11, 2019, the registrant had 2,610,568 shares of common stock, $0.01 par value per share, outstanding.

 

 

Table of Contents

 

MedAmerica Properties Inc.

 

Form 10-Q

 

Table of Contents

 

Part I - Financial Information

1

 

 

Item 1.

Financial Statements

1

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

1011

 

 

Cautionary Statement Concerning Forward-Looking Statements

1011

 

 

Overview

1011

 

 

Critical Accounting Policies and Estimates

1112

 

 

Results from Operations

1113

 

 

General and Administrative Expenses

1113

 

 

Interest Expense

1214

Income Tax Expense

12

14

 

 

Net (Loss) IncomeLoss Attributable to Common Shareholders

1214

 

 

Financial Condition and Liquidity

1214

 

 

Off-Balance Sheet Arrangements

1315

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

1315

 

 

 

Item 4.

Controls and Procedures

1416

 

 

 

Part II - Other Information

1416

 

 

Item 1.

Legal Proceedings

1416

    Item 1A.

Risk Factors

16

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

1416

 

 

 

Item 3.

Defaults Upon Senior Securities

1416

 

 

 

Item 4.

Mine Safety Disclosures

1416

 

 

 

Item 5.

Other Information

1416

 

 

 

Item 6.

Exhibits

1517

 

 

 

Signatures

1619

 

 

Table of Contents

 

Part I - Financial Information

Item 1. Financial Statements

 

MedAmerica Properties Inc.

Condensed Consolidated Balance Sheets

 

 

September 30, 2018

  

December 31, 2017

  

September 30, 2019

  

December 31, 2018

 

 

(Unaudited)

      

(unaudited)

     
ASSETS          

Current assets

                

Cash and equivalents

 $262,360  $708,382  $32,233  $139,721 

Prepaid insurance and other assets

  45,888   38,191 

Prepaid insurance and other current assets

  11,030   33,784 

Total current assets

  308,248   746,573   43,263   173,505 

Other assets

                

Equipment & furnishings, net

  19,384   21,808   16,152   18,576 

Total other assets

  19,384   21,808   16,152   18,576 
                

Total assets

 $327,632  $768,381  $59,415  $192,081 
                

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

        

LIABILITIES AND STOCKHOLDERS' EQUITY

        

Current liabilities

                

Accounts payable and accrued expenses

 $43,057  $66,319  $267,291  $92,566 

Accrued dividends

  27,361   27,361   27,361   27,361 

Loan payable - insurance financing

  45,669   33,191   -   33,184 

Total current liabilities

  116,087   126,871   294,652   153,111 
                

Total liabilities

  116,087   126,871  $294,652  $153,111 
          

Stockholders' equity (deficit)

        

Series A Preferred stock, $0.01 par value, 20,000 shares authorized, 500 issued at September 30, 2018 and December 31, 2017

  5   5 

Common stock, $0.01 par value, 50,000,000 shares authorized, 2,610,568 issued at September 30, 2018 and December 31, 2017

  26,105   26,105 

Stockholders' equity

        

Series A Preferred stock, $0.01 par value, 20,000 shares authorized, 500 issued at September 30, 2019 and December 31, 2018

  5   5 

Common stock, $0.01 par value, 50,000,000 shares authorized, 2,610,568 issued at September 30, 2019 and December 31,2018

  26,105   26,105 

Additional paid-in capital

  111,861,799   111,861,799   111,861,799   111,861,799 

Accumulated deficit

  (111,676,364)  (111,246,399)  (112,123,146)  (111,848,939)

Total stockholders' equity (deficit)

  211,545   641,510 

Total stockholders' equity (Deficit)

  (235,237)  38,970 
                

Total liabilities and stockholders' equity (deficit)

 $327,632  $768,381 

Total liabilities and stockholders' equity

 $59,415  $192,081 

 

See Notes to Condensed Consolidated Financial Statements

 

1

Table of Contents

 

MedAmerica Properties Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

 

 

Nine months ended September 30,

  

Three months ended September 30,

  

Nine months ended September 30,

  

Three months ended September 30,

 
 

2018

  

2017

  

2018

  

2017

  

2019

  

2018

  

2019

  

2018

 
                                

General & administrative expenses

 $428,941  $368,331  $133,399  $261,461  $272,894  $428,941  $9,034  $133,399 

Loss from operations

  (428,941)  (368,331)  (133,399)  (261,461)  (272,894)  (428,941)  (9,034)  (133,399)

Interest expense

  (1,024)  (16,618)  (256)  (1,230)  (1,313)  (1,024)  (328)  (256)

Net loss

 $(429,965) $(384,949) $(133,655) $(262,691) $(274,207) $(429,965) $(9,362) $(133,655)
                                

Dividends for the benefit of preferred stockholders:

                                

Preferred stock dividends

  (3,750)  (3,750)  (1,250)  (1,250)  (3,750)  (3,750)  (1,250)  (1,250)

Deemed dividends on preferred stock conversion

  -   (148,125)  -   - 

Net loss attributable to common stockholders

 $(433,715) $(536,824) $(134,905) $(263,941) $(277,957) $(433,715) $(10,612) $(134,905)
                                
                                

Basic and diluted average number of common shares outstanding:

  2,610,568   1,185,284   2,610,568   1,438,206 

Basic and diluted average number of common shares outstanding

  2,610,568   2,610,568   2,610,568   2,610,568 
                                

Net loss per common share basic and diluted

 $(0.17) $(0.45) $(0.05) $(0.18) $(0.11) $(0.17) $(0.00) $(0.05)

 

See Notes to Condensed Consolidated Financial Statements

 

2

Table of Contents

 

MedAmerica Properties Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

  

Nine months ended September 30,

 
  

2018

  

2017

 

Cash flows used in operating activities:

        

Net loss

 $(429,965) $(384,949)

Adjustments to reconcile net loss to net cash used in operating activities:

        

Depreciation

  2,424   - 

Note assumed by related party

  -   (277,756)

Changes in assets and liabilities:

        

Increase/(Decrease) in prepaid expenses and other assets

  37,972   31,703 

Decrease/(Increase) in accounts payable and accrued expenses

  (23,262)  110,577 

Net cash used in operating activities

  (412,831)  (520,425)
         

Cash flows provided by investing activities:

        

Acquisition of equipment and furnishings

  -   (22,716)

Decrease in property deposits

  -   85,000 

Net cash provided by investing activities

  -   62,284 
         

Cash flows provided by financing activities:

        

Payment of demand loan & accrued interest - related party

  -   (363,208)

Proceeds on demand loan - related party

  -   169,138 

Payment of note payable - insurance financing

  (33,191)    

Proceeds from common stock subscribed, net of expenses

  -   1,803,665 

Net cash (used in) provided by financing activities

  (33,191)  1,609,595 
         

Net increase (decrease) in cash

  (446,022)  1,151,454 

Cash at beginning of period

  708,382   450 

Cash at end of period

 $262,360  $1,151,904 
         

Supplemental disclosure of cash flow information:

        

Cash paid during the period for:

        

Interest

 $1,024  $16,618 

Franchise taxes

 $5,650  $- 
         

Non cash financing activities:

        
Financed insurance $45,669  $

 

-

 

Deemed dividend on preferred stock conversion

 $-  $148,125 

Issuance of common shares

 $-  $888,774 
  

Nine months ended September 30,

 
  

2019

  

2018

 

Cash flows used in operating activities:

        

Net loss

 $(274,207) $(429,965)

Adjustments to reconcile net loss to net cash used in operating activities:

        

Depreciation

  2,424   2,424 

Changes in assets and liabilities:

        

Decrease in prepaid expenses and other assets

  22,754   37,972 

(Decrease)/Increase in accounts payable and accrued expenses

  174,725   (23,262)

Net cash used in operating activities

  (74,304)  (412,831)
         

Cash flows used in financing activities:

        

Payment of note payable - insurance financing

  (33,184)  (33,191)

Net cash used in financing activities

  (33,184)  (33,191)
         

Net decrease in cash

  (107,488)  (446,022)

Cash at beginning of period

  139,721   708,382 

Cash at end of period

 $32,233  $262,360 
         

Supplemental disclosure of cash flow information:

        

Cash paid during the period for:

        

Interest

 $1,313  $1,024 

Franchise taxes

 $-  $5,650 
         

Non cash financing activities:

        

Prepaid insurance loan financing

 $-  $45,669 

 

See Notes to Condensed Consolidated Financial Statements

 

3

Table of Contents

MedAmerica Properties Inc.

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

(unaudited)

  

Nine Month Period Ended September 30, 2019

 
  

Common Stock

  

Common

Stock

  

Preferred Stock

  

Additional

  

Accumulated

  

Treasury Stock

     
  

Shares

  

Amount

  Subscribed  

Shares

  

Amount

  

Paid in Capital

  

Deficit

  

Shares

  

Amount

  

Total

 

Stockholders’ (deficit) equity December 31, 2018

  2,610,568  $26,105   -   500  $5  $111,861,799  $(111,848,939)  -   -  $38,970 

Net loss for the nine months ended September 30, 2019

                          (274,207)          (274,207)

Stockholders’ equity (deficit) September 30, 2019

  2,610,568  $26,105  $-   500  $5  $111,861,799  $(112,123,146)  -  $-  $(235,237)

  

Nine Month Period Ended September 30, 2018

 
  

Common Stock

  

Common

Stock

  

Preferred Stock

  

Additional

  

Accumulated

  

Treasury Stock

     
  

Shares

  

Amount

  Subscribed  

Shares

  

Amount

  

Paid in Capital

  

Deficit

  

Shares

  

Amount

  

Total

 
                                         
                                         

Stockholders’ (deficit) equity December 31, 2017

  2,610,568  $26,105   -   500  $5  $111,861,799  $(111,246,399)  -   -  $641,510 

Net loss for the nine months ended September 30, 2018

                          (429,964)          (429,965)

Stockholders’ equity September 30, 2018

  2,610,568  $26,105  $-   500  $5  $111,861,799   (111,676,363)  -  $-  $211,545 

  

Three Month Period Ended September 30, 2019

 
  

Common Stock

  

Common

Stock

  

Preferred Stock

  

Additional

  

Accumulated

  

Treasury Stock

     
  

Shares

  

Amount

  Subscribed  

Shares

  

Amount

  

Paid in Capital

  

Deficit

  

Shares

  

Amount

  

Total

 

Stockholders’ (deficit) equity June 30, 2019

  2,610,568  $26,105   -   500  $5  $111,861,799  $(112,113,784)  -   -  $(225,875)

Net loss for the three months ended September 30, 2019

                          (9,362)          (9,362)

Stockholders’ equity (deficit) September 30, 2019

  2,610,568  $26,105  $-   500  $5  $111,861,799  $(112,123,146)  -  $-  $(235,237)

  

Three Month Period Ended September 30, 2018

 
  

Common Stock

  

Common

Stock

  

Preferred Stock

  

Additional

  

Accumulated

  

Treasury Stock

     
  

Shares

  

Amount

  Subscribed  

Shares

  

Amount

  

Paid in Capital

  

Deficit

  

Shares

  

Amount

  

Total

 
                                         
                                         

Stockholders’ (deficit) equity June 30, 2018

  2,610,568  $26,105   -   500  $5  $111,861,799  $(111,542,709)  -   -  $345,200 

Net loss for the three months ended September 30, 2018

                          (133,654)          (133,655)

Stockholders’ equity September 30, 2018

  2,610,568  $26,105  $-   500  $5  $111,861,799   (111,676,363)  -  $-  $211,545 

See Notes to Condensed Financial Statements

4

Table of Contents

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Note 1. Nature of Operations

 

MedAmerica Properties Inc. (the “Company” or “MedAmerica”) was originally organized under the laws of the Commonwealth of Massachusetts in 1985, under the name VMS Hotel Investment Trust, for the purpose of investing in mortgage loans. The Company was subsequently reorganized as a Delaware corporation in 1987 and changed its name to B.H.I.T. Inc. In 2010, the Company changed its name from B.H.I.T. Inc. to Banyan Rail Services Inc. From 2009 to 2012, the Company experienced severe losses from an operating subsidiary in the rail services sector. In 2016, after exploring various industries and researching numerous companies, the board of directors elected to pursue investing in commercial real estate. In 2018, the Company began negotiating a transaction with a sponsor of real estate properties located in the United States. The Company is pursuingentered into a letter of intent with the acquisitionsponsor in September 2018, which was amended in November 2018 and management of strategically located medical office buildings.April 2019.

 

InOn May 28, 2019, the Company and certain of its newly formed subsidiaries described further below entered into 19 separate agreements and plans of merger (collectively, the “Merger Agreements” and the “Transaction”) with each of Broad Street Realty, LLC (the “BSR”), Broad Street Ventures, LLC (“BSV”) and each of BSV Avondale LLC, BSV Colonial Investors LLC, BSV Coral Hills Investors LLC, BSV Crestview Square LLC, BSV Cromwell Parent LLC, BSV Cypress Point Investors LLC, BSV Dekalb LLC, BSV Greenwood Investors LLC, BSV Highlandtown Investors LLC, BSV Hollinswood LLC, BSV Lamont Investors LLC, BSV Lamonticello Investors LLC, BSV LSP East Investors LLC, BSV Patrick Street Member LLC, BSV Premier Brookhill LLC, BSV Spotswood Investors LLC and BSV West Broad Investors LLC (collectively, the “Broad Street Entities”). Pursuant to the Merger Agreements, in a series of 19 mergers, BSR, BSV and each Broad Street Entity will merge with and into a subsidiary of the Company (the “Merger Subs”) with BSR, BSV and each Broad Street Entity surviving (collectively, the “Mergers”). MedAmerica following the completion of the Mergers is referred to herein as the “Combined Company.” Pursuant to the Merger Agreements, the name of the Combined Company will be changed to “Broad Street Realty, Inc.” prior to the closing of the Mergers.

On April 2017,9, 2019, our board of directors approved a proposed amendment to our bylaws to remove Section 2.2 of our bylaws, which prohibited the Company from compensating our directors (the “bylaw amendment”) and recommended to our stockholders adoption of the bylaw amendment and ratification of past compensation paid by MedAmerica to our directors (the “board compensation”). Delaware law permits the holders of a majority of our outstanding shares of common stock approvedto approve the bylaw amendment and ratify the board compensation by written consent amendmentswithout holding a meeting. The amendment to the Company’s certificate of incorporation to (1) change the name of the Company from “Banyan Rail Services Inc.” to “MedAmerica Properties Inc.,” and (2) effect a 1 for 10 reverse stock split of the issued and outstanding shares of common stock of the Company. On June 15, 2017, the Company filed these amendments with the Secretary of State of the State of Delaware and the name change and reverse stock splitBy-laws became effective with the Financial Industry Regulatory Authority, Inc. (“FINRA”)May 17, 2019.  This amendment had no impact on June 20, 2017. As appropriate, all common stock share quantities have been updated to reflect the 1 for 10 reverse stock split.previously reported results of operations.

 

 

 

Note 2. Principles of Consolidation and Basis of Presentation

 

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany account balances have been eliminated in consolidation. The accompanying Financial Statements give effect to all adjustments necessary to present fairly the financial position and results of operations and cash flows of the Company.  In January 2019 the Company anddissolved all of its subsidiaries.pre-merger subsidiaries which were inactive. In May 2019 the Company formed various subsidiaries which are inactive except for the execution of the Merger Agreements referenced above.

 

 

Note 3. Immaterial Error Correction

The Company has corrected an immaterial error in its previously filed Form 10-Q, for the quarter ended September 30, 2017. Net loss attributable to common stockholders decreased by $148,125 for the three months ended September 30, 2017 and the net loss per common share basic and diluted decreased by $(0.10) for the three months ended September 30, 2017 to reflect the deemed dividend on preferred stock exchange which was effective June 30, 2017 and originally reported in September 30, 2017 (See Note 7).

 

 

 

Note 43.Liquidity and Profitability

 

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Accordingly, the consolidated financial statements do not include any adjustments relating to the recoverability of assets and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company management believes that cash on hand and a line of credit from a related party (see Note 10) will be adequate to fund its limited overhead and other cash requirements for the next twelve months.

 

During 2017 the Company completed a private placement of its common stock, raising $1,940,005. AtAs of September 30, 2018,2019, the Company had a cash balance of approximately $262,000$32,233 and negative working capital of approximately $192,000.$251,000.

 

We have undertaken, and will continue to implement, various measures to address our financial condition, including:

 

 

Consummate the acquisition of 17 shopping centers referred to in Note 1. We have executed merger agreements however there can be no assurance we will be able to consummate the Transaction.

BSR has agreed to pay the Company, effective July 1 through November 30, 2019, $25,000 per month if the closing of the Transaction has not been completed by the end of the previous month.

The Company received $75,000 from BSR for the three and nine months ended September 30, 2019 and recorded the amount received as an offset to general & administrative expenses paid by the Company related to the merger.

               If the Transaction is not consummated the Company intends to to focus on:

Curtailing costs and consolidating operations, where feasible.

Seeking debt, equity and other forms of financing, including funding through strategic partnerships.

Reducing operations to conserve cash.

Investigating and pursuing transactions with third parties, including strategic partnerships.

Adding board membertransactions and senior advisor with extensive real estate experience.relationships.

 

The Company management believes that these measures, coupled with cash on hand, the $25,000 per month payment from BSR and a line of credit from a related party (see Note 9) will be adequate to fund its limited overhead and other cash requirements for the next twelve months. However, thereThere can be no assurance that we will be able to consummate the Transaction or secure the additional funding we need. If our efforts to do so are unsuccessful, we will be required to further reduce or eliminate our operations. However, Boca Equity Partners LLC (“BEP”), an entity controlled by our chairman, has committed to funding operations through April 2021 in the event the Transaction does not close.

 

 

 

Note 5.4. Summary of Significant Accounting Policies

 

UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL INFORMATIONUnaudited Interim Condensed Consolidated Financial Information

 

The unaudited interim condensed consolidated financial statements of the Company as of September 30, 20182019 for the three and nine months ended September 30, 20182019 and 20172018 included herein have been prepared in accordance with the instructions for Form 10-Q under the Securities Exchange Act of 1934, as amended, and Article 108 of Regulation S-X under the Securities Act of 1933, as amended. Certain information and note disclosures normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations relating to interim condensed consolidated financial statements.

  

In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position of the Company at September 30, 20182019 and the results of its operations and its cash flow for the three and nine months ended September 30, 20182019 and 2017.2018. The results of operations and cash flows for such periods are not necessarily indicative of results expected for the full year or for any future period.

 

Use of Estimates

 

The preparation of financial statements, in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"), requires management to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses and disclosures of contingent assets and liabilities at the date and period ending of the financial statements. Actual results could differ from those estimates.

 

Cash

 

The Company considers all cash, bank deposits and highly liquid investments with an original maturity of three months or less to be cash equivalents. From time to time our cash deposits exceed federally insured limits.

 

Equipment and Furnishings

 

Equipment and furnishings are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, which range from 3 to 7 years. Expenditures for repairs and maintenance are charged to expense as incurred. For assets sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in income for the period statement of operations.

 

Fair Value of Financial Instruments

 

Recorded financial instruments as of September 30, 2018,2019, consist of cash and cash equivalents, accounts payable, accrued liabilities and short-term obligations. The related fair values of these financial instruments approximated their carrying values due to either the short-term nature of these instruments or based on the interest rates currently available to the Company.

 

Income (Loss) Per Common Share

 

The Company computes net income (loss) per common share in accordance with the provision included in Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) 260, Earnings per Share. Under ASC 260, basic and diluted income (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares and common share equivalents outstanding during the period. Basic income (loss) per common share excludes the effect of potentially dilutive securities, while diluted income (loss) per common share reflects the potential dilution that would occur if securities or other contracts to issue common shares were exercised for, converted into or otherwise resulted in the issuance of common shares. The Company’s potentially dilutive securities are not included in the computation of diluted loss per share because their impact is anti-dilutive due to the net loss.

 

 

Income Taxes

 

The Company accounts for our income taxes using FASB ASC Topic 740, " Income Taxes ", "Income Taxes", which requires the recognition of deferred tax liabilities and assets for expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.

 

The Company follows the provisions regardingAccounting for Uncertainty in Income Taxes, which require the recognition of a financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. We applied these changes to tax positions for our fiscal years ending December 31, 2018 and December 31, 2017. We had no material unrecognized tax benefits and no adjustments to our financial position, results of operations or cash flows that were required. Generally, federal, state and local authorities may examine the Company's tax returns for three years from the date of filing. We do not expect that unrecognized tax benefits will increase within the next twelve months. We recognize accrued interest and penalties related to uncertain tax positions as income tax expense. 

 

Retained Earnings Distributions

 

The Company’s preferred stockholders are entitled to receive payment before any of the common stockholders upon a liquidation of the Company, and we cannot pay dividends on our common stock unless we first pay dividends required by our preferred stock.

 

Preferred Stock Dividends

 

The holder of Series A Cumulative Preferred Stock (“Preferred Stock”) are entitled to receive cumulative, non-compounded, cash dividends on each outstanding share of Preferred Stock at the rate of 10.0% of the issuance price per annum (“Preferred Dividends”), which began accumulating on January 1, 2010. The Preferred Dividends are payable semiannually to the holder of Preferred Stock, when and as declared by the Board of Directors.

 

Recently Issued Accounting Pronouncements

 

Management has determined that all recently issued accounting pronouncements will not have a material impact on the Company’s financial statements or do not apply to the Company’s operations.

 

 

 

Note 6.5. Equipment and Furnishings

 

The amount of equipment and furnishings as of September 30, 2019 and December 31, 2018, are as follows:

 

Description

 

September 30, 2019

  

December 31, 2018

 

Office equipment and furnishings

 $21,829  $21,829 

Computer equipment

  787   787 

Total

  22,616   22,616 

Less accumulated depreciation

  (6,464)  (4,040)

Equipment and furnishings, net

 $16,152  $18,576 

 

Description

  September 30, 2018 

December 31, 2017

 

Office equipment and furnishings

 $

21,829

 $21,829 

Computer equipment

  

787

  787 

Total

  

22,616

  22,616 

Less accumulated depreciation

  (3,232) (808)

Equipment and furnishings, net

 $19,384 $21,808 

 

Depreciation expense related to equipment and furnishings amounted to $808 and $2,424 for the three and nine months ended September 30, 2019 and the three and nine months ended September 30, 2018.

 

 

 

Note 7.6. Preferred Stock and Common Stock

Stock Split

In April 2017, the board of directors and the then majority shareholder approved a 1 for 10 reverse stock split (“Stock Split”) of the issued and outstanding shares of common stock of the Company. On June 15, 2017, the Company filed an amendment to its certificate of incorporation with the Delaware Secretary of State effecting the Stock Split. The Stock Split became effective with the Financial Industry Regulatory Authority, Inc. (“FINRA”) on June 20, 2017.

Pursuant to the Stock Split, each outstanding share of the Company’s common stock was automatically exchanged for one - tenth of a share. As a result, each stockholder now owns a reduced number of shares of the Company’s common stock. The Stock Split affects all stockholders uniformly and does not affect any stockholder’s percentage ownership in the Company or the proportionate voting rights and other rights and preferences of the stockholders, except for adjustments that may result from the treatment of fractional shares, which have been rounded to the nearest whole share. The number of the Company’s authorized shares of common stock was not affected by the Stock Split.

Private Placement

From February 10, 2017 through December 31, 2017, the Company accepted subscriptions of $1,940,005 for unregistered shares of the Company’s common stock for $1.50 a share (the “2017 Private Placement”). The issuances of common stock were made in reliance on Section 4(a)(2) of the Securities Act of 1933 for the offer and sale of securities not involving a public offering and Rule 506(b) under the Securities Act. The proceeds from the 2017 Private Placement are being used for working capital and to fund operations. The Company issued 1,293,334 shares of common stock under the 2017 Private Placement, along with 2,500 shares of common stock under a prior private placement.

Preferred Stock Exchange

In April 2017, the Company offered our preferred shareholders shares of our common stock in exchange for their Series A cumulative preferred stock (“Preferred Stock”) and accumulated preferred dividends outstanding as of December 31, 2016. Pursuant to the offer, each share of Preferred Stock would be exchanged for 20 shares of (post-split) common stock and each dollar of preferred dividend would be exchanged for 0.2 shares of common stock. All preferred shareholders, except one, accepted the offer resulting in the conversion of 9,875 shares of Preferred Stock and $301,656 of accumulated preferred dividends into 257,831 shares of common stock, which were issued in the third quarter of 2017. The effective date of the exchange is June 30, 2017. This exchange resulted in deemed dividends on preferred stock conversion of $148,125.

Subsequent to the reverse stock split, the private placement and the preferred stock exchange, there are 2,610,568 shares of common stock issued and outstanding, consisting of 1,059,581 shares after the reverse stock split, 1,293,156 shares from the private placement and 257,831 shares from the preferred stock and preferred dividend exchange.

 

Preferred Stock Dividends

 

The holder of Preferred Stock areis entitled to receive cumulative, non-compounded cash dividends on each outstanding share of Preferred Stock at the rate of 10.0%10% of the Issuance Price per annum (“Preferred Dividends”), which began to accrue on January 1, 2010. Preferred Dividends are payable semiannually to the holder of Preferred Stock. Any Preferred Dividends due and unpaid on any Payment Date, whether or not declared by the board of directors, shall accrue with any other due and unpaid Preferred Dividends, regardless of whether there are profits, surplus or other funds of the Company legally available for payment of dividends.

 

Substantially all the Preferred stockholders had previously agreed to accept common stock in lieu of cash for payment of Preferred Dividends. In February 2016, the Company issued 29,856 shares of common stock in lieu of $29,249 of Preferred Dividends for those Preferred stockholders who accepted the common stock in lieu of the cash offer. The total accrued but unpaid Preferred Dividends is $27,361 as of September 30, 20182019 and December 31, 2017.2018. An additional $8,750$13,750 and $10,000 of cumulative Preferred Dividends are undeclared and unaccrued as of September 30, 2019 and December 31, 2018, respectively, and are not included in the balance sheet.

 

Common Stock

 

As of September 30, 2018,2019 the Company’s board of directors and officers beneficially own 838,060 shares of the Company’s common stock or 32.10% of the outstanding common stock. Included in the 838,060 shares is 91,348 shares owned by Banyan Rail Holdings LLC and 351,966are 475,314 shares owned by Marino Family Holdings LLC companieswhich is controlled by our chairman, Gary O. Marino. 79,703 shares are held by the Marino Family Dynasty Trust.            

 

 

 

Note 8.7. Earnings (Loss) per Share

 

The Company excluded from its diluted earnings per share calculation 500 and 10,375 common shares issuable upon conversion of shares of convertible preferred stockPreferred Stock that were outstanding September 30, 2019 and 2018 as well as 70,000 and 60,000 stock70,000 options that were outstanding atas of September 30, 20182019 and 2017,2018, respectively, as their inclusion would be anti-dilutive.

 

.

 

 

Note 9.8. Stock-Based Compensation

 

On August 23, 2017, the Company issued an aggregate of 60,000 stock options to its directors and officers. The related stock compensation expense was not material.

 

On June 11, 2018, the Company issued an aggregate of 10,000 stock options to a director.director as compensation for board services. The related stock compensation expense was not material.

 

The Company previously had stock option agreements with its directors and officers. Details of options activity is as follows:

 

 

Number of

Shares

  

Weighted

Average

Exercise Price

per Share

  

Weighted

Average

Fair Value at

Grant Date

  

Weighted

Average

Remaining Contractual

Life

  

Intrinsic

Value

  

Number of

Shares

  

Weighted

Average

Exercise Price

per Share

  

Weighted

Average Fair

Value at Grant

Date

  

Weighted

Average

Remaining

Contractual Life

  

Intrinsic

Value

 

Balance December 31, 2016

  -  $-   -   -   -   -  $-   -   -   - 

Options granted

  60,000   8.00   -   -   -   60,000   8.00   -   -   - 

Options exercised

  -   -   -   -   -   -   -   -   -   - 

Options expired

  -   -   -   -   -   -   -   -   -   - 

Balance December 31, 2017

  60,000  $8.00  $-   -  $-   60,000  $8.00  $-   4.75  $- 

Options granted

  -   -   -   -   -   10,000   6.00   -   -   - 

Options exercised

  -   -   -   -   -   -   -   -   -   - 

Options expired

  -   -   -   -   -   -   -   -   -   - 

Balance March 31, 2018

  60,000  $8.00  $-   -  $- 

Balance December 31, 2018

  70,000  $7.71  $-   3.86  $- 

Options granted

  10,000   6.00   -   -   -   -   -   -   -   - 

Options exercised

  -   -   -   -   -   -   -   -   -   - 

Options expired

  -   -   -   -   -   -   -   -   -   - 

Balance June 30, 2018

  70,000  $7.71  $-   -  $- 

Options granted

  -   -   -   -   - 

Options exercised

  -   -   -   -   - 

Options expired

  -   -   -   -   - 

Balance September 30, 2018

  70,000  $7.71  $-   4.11  $- 

Balance September 30, 2019

  70,000  $7.71  $-   3.11  $- 

 

The fair values of stock options are estimated using the Black-Scholes method, which takes into account variables such as estimated volatility, expected holding period, dividend yield, and the risk-free interest rate. The risk-free interest rate is the five-year treasury rate at the date of grant. The expected life is based on the contractual life of the options at the date of grant. All 70,000 outstanding options were fully vested at grant date. The intrinsic value is not material.

 

89

 

 

Note 10.9. Related Party Relations and Transactions

 

Gary O. Marino, the Company’s chairman of the board, is the chairman, president, and chief executive officer of Boca Equity Partners LLC (“BEP”), Patriot Equity LLC (“Patriot”), Banyan Medical Partners LLC (“BMP”), and Banyan Surprise Plaza LLC (“BSP”). Mr. Marino owns 100% of Patriot, Patriot owns 100% of BMP and BSP through and along with other wholly owned subsidiaries. Mr. Marino, Mr. Paul S. Dennis, a memberMr. Donald Denbo and Mr. Bennett Marks, members of the Company's board of directors, and Mr. Donald S. Denbo,Joseph Bencivenga, a member of the Company'sCompany’s board of directors and the Company’s President and Chief Executive Officer, and Ms. Patricia Sheridan, the Company’s Chief Financial Officer, also hold membership interests in BEP.

During 2016, the Company established BMP, and certain other subsidiaries wholly-owned by BMP. The Company formed these entities to acquire medical office buildings in the United States. The Company was unable to raise the capital needed to consummate the first medical building opportunity. On March 9, 2017, the Company sold BMP and BMP’s wholly-owned subsidiaries to Patriot. The selling price was $277,756 in the form of BMP assuming a portion of the Company’s note payable balance due to BEP. The consideration of $277,756 was used to recoup the $110,000 in property deposits as of December 31, 2016 and reimbursement of $117,756 of other 2016 and 2017 expenses incurred by the Company on behalf of BMP. This reimbursement of expenses is offset in general and administrative expenses as of June 30, 2017, which caused general and administrative expenses to have a credit balance of $7,270 during that quarter.

 

On July 27, 2016, the Company entered into a Demand Note and Loan Agreement (the “Note”) with BEP providing for draws of up to $250,000. Loans under the Note bore interest at an annual rate of 10% and outstanding principal and interest were due on demand. This Note was cancelled and terminated on December 31, 2016 when the Company entered into a new Demand Note and Loan Agreement (the “New Note”) with BEP for $471,826. The New Note representsrepresented advances from BEP under the New Note, payments made since the date of the New Note and interest accrued thereon. The New Note bore interest at the rate of 10% per annum and iswas payable upon demand. BEP is committed to making advances to the Company under the New Note as the Company may from time to time request. The balance drawn on the New Note including accrued interest was paid in full May 31, 2017. In October 2019, BEP agreed to extend the New Note to April 2021 in exchange for an extension fee of $18,873. The New Note remains available to the Company to draw upon.upon and the balance as of the date of this report due under the New Note is $0 as of September 30, 2019 and December 31, 2018.  The New Note will be cancelled upon the repayment of principal and interest, if any, and consummation of the Transaction described in Note 1.  

 

On September 13, 2018, MedAmericathe Company entered into an office lease and administrative support agreement (the “Agreement”“2018 Lease Agreement”) with BEP. The 2018 Lease Agreement has a month-to-month term commencing on September 1, 2018. The 2018 Lease Agreement provides for the Company’s use of a portion of BEP’s offices and certain overhead items at the BEP offices such as space, utilities and other administrative services for $5,000 a month. The 2018 Lease Agreement replaces the June 8, 2017 office lease and administrative support agreement between the Company and BEP. Total expense incurred under these agreements amounted to $125,000$45,000 and $93,025$90,000 for the nine months ended September 30, 20182019 and 2017, respectively and $35,000 and $45,000 for the three months ended September 30, 2018, and 2017, respectively.

 

During 2018 the Company's President and CEO performed work for International Rail Partners LLC (“IRP”), an entity controlled by the Company’s Chairman. The Company billed back IRP for compensation and expenses in the amount of $125,078 and $13,211$125,090 for the nineyear ended December 31, 2018 of which $39,375 related to compensation and threeexpenses for the nine months ended September 30, 2018.

 

The Company’s directors have not received cash compensation for their services in 20182019 or 20172018 but were compensated with stock options. See footnote 9Note 8 Stock-Based Compensation for further discussion. In the third quarter of 2017, the Company hired a new president and chief executive officer and a new chief financial officer who are husband and wife. Also, in the third quarter of 2017, the Company issued 15,000 common stock options to the president and CEO and 45,000 shares to other board members and officers. The related stock compensation was not material.

 

As of December 31, 2018 and September 30, 2018,2019, the Company’s board of directors and officers beneficially own 838,060 shares of the Company’s common stock or 32.10% of the outstanding common stock. Included in the 838,060 shares are 91,348 shares owned by Banyan Rail Holdings LLC and 351,966475,314 shares owned by Marino Family Holdings LLC companieswhich is controlled by our chairman, Gary O. Marino. 79,703 shares are held by the Marino Family Dynasty Trust.

 

Paul Dennis, director and previously interim president, interim chief executive officer and interim chief financial officer, participated in the 2017 Private Placement investing $150,000 for 100,000 shares of common stock. 

 

 

 

Note 11.10. Subsequent Events

 

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements were issued for potential recognition or disclosure. The Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

 

910

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion should be read in conjunction with the accompanying unaudited Financial Statements and notes thereto included under Part I, Item 1 of this Quarterly Report on Form 10-Q. In addition, reference should be made to our audited Consolidated Financial Statements and notes thereto and related “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC”).

 

Cautionary Statement Concerning Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains information about the Company, some of which includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 including statements regarding our beliefs regarding opportunities for strong cash flow and increased stock value for our stockholders from investingthe timing relating to the Merger Transaction described in medical office buildings.this report. Forward-looking statements are statements other than historical information or statements about our current condition. You can identify forward-looking statements by the use of terms such as “believes,” “contemplates,” “expects,” “may,” “will,” “could,” “should,” “would,” or “anticipates,” other similar phrases, or the negatives of these terms. We have based the forward-looking statements relating to our operations on our current expectations, estimates and projections about us and the markets we serve. We caution you that these statements are not guarantees of future performance and involve risks and uncertainties. These statements should be consideredrisks include internal issues relating to the shopping center limited liability companies including obtaining the required investor and lender consents. See also the Risk Factors in conjunction with the discussion in Part I, the information set forth under Item 1A “Risk Factors” and with the discussion of the business included in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” of our 20172018 Annual Report on Form 10-K, filed with the SEC on April 2, 2018.11, 2019. We have based many of these forward-looking statements on assumptions about future events that may prove to be inaccurate. Accordingly, the actual outcomes and results may differ materially from what we have expressed or forecast in the forward-looking statements. Any differences could result from a variety of factors, including the following:

 

Successfully raising capital to fund our operations;

Successfully finding medical office buildings to acquire with co-investment partners;

Successfully finding financing to acquire identified medical office buildings;

Successfully managing and operating medical office buildings acquired;Closing the proposed strategic transaction discussed in this report; and

Any of our other plans, objectives, expectations or intentions contained in this report that are not historical facts.

 

You should not place undue reliance on our forward-looking statements, which reflect our analysis only as of the date of this report. The risks and uncertainties listed above and elsewhere in this report and other documents that we file with the SEC, including our annual report on Form 10-K, quarterly reports on Form 10-Q, and any current reports on Form 8-K, must be carefully considered by any investor or potential investor in the Company. We undertake no obligation to update forward-looking statements, except as required by law.

 

Overview

 

MedAmerica is a real estate management company with limited operations. During 2018, up to the time we were introduced to the commercial real estate company described below, we were focused on seeking to acquire medical office buildings. None of our discussions concluded in any acquisitions.

As part of our search, we were introduced to the sponsor of multiple commercial real estate properties located in the United States in late 2018. After that introduction and continuing to date, we have been engaged in negotiations and we executed merger agreements and plan on consummating a strategic transaction (the “Transaction”) with MedAmerica becoming the owner of between 12 and 17 retail shopping centers, the sponsor of such properties appointing five of seven members of our board of directors, and the sponsor and its investors owning a substantial majority of our common stock and the sponsor and its investors ending up as our principal shareholders. Completion of the Merger Transaction is subject to a number of closing conditions, including obtaining certain financing. There can be no assurance that the Transaction will be consummated.

Our History

The Company was originally organized under the laws of the Commonwealth of Massachusetts in 1985, under the name VMS Hotel Investment Trust, for the purpose of investing in mortgage loans. The Company was subsequently reorganized as a Delaware corporation in 1987 and changed its name to B.H.I.T. Inc. In 2010, the Company changed its name from B.H.I.T. Inc. to Banyan Rail Services Inc. From 2009 to 2012, the Company experienced severe losses from an operating subsidiary in the rail services sector. In 2016, after exploring various industries in 2016,and researching numerous companies, the board of directors determinedelected to pursue investing in commercial real estate. In 2017 the sourcing, financing, asset management and co-investmentCompany changed its name to MedAmerica Properties Inc.

11

Table of well-located medical office buildings throughout the United States with the intention of aggregating multiple properties within certain locations allowing us to gain efficiencies and diversify risk. We will source, provide all due diligence and oversee the financing for co-investment partners to acquire medical office buildings in a price range typically too small for REIT investing. We will then asset and property manage the portfolios and determine the optimal exit strategy.Contents

The Transaction

 

We will seek investmentshave entered into merger agreements with strong fundamentals in the highly-desired healthcare real estate sector that continues to grow by demand that is supported by expectationssponsor of an increase in the aging baby boomer population. We are focused on opportunistic medical office real estate investmentsseveral limited liability companies, each of which owns a separate shopping center located in the sunbelt states. ManagementUnited States. The merger agreements govern our acquisition of the shopping centers and  the proposed capitalization of the combined company.  The Transaction is lookingexpected to close in these attractive geographic locations for investmentstwo or more stages.  Assuming we close the Transaction and acquire all of the shopping centers, we will issue common stock to the sponsor and the current investors in the shopping centers who collectively will own approximately 92.6% of our common stock on a fully diluted basis with our current shareholders owning approximately 7.4%.  Closing is subject to a number of conditions including obtaining satisfactory resolution of the proposed accounting treatment, our board of director’s receipt of a fairness opinion, lender and other third-party consents, obtaining $47 million of new financing and other customary closing conditions.  Please see more detailed information about the Transaction contained in our Form 8-K filed on May 28, 2019.

It is currently estimated that meet its criteria. We believe that investingthe Transaction would be expected to be consummated in medical office buildings will generate strong cash flow and produce significantly increased value for our stockholders. Although we believe the acquisition and managementfourth quarter of medical office buildings is fundamentally sound,2019, but there iscan be no assurance that there will not be delays. We cannot assure you that we will be successful in this endeavor or thatclose the Transaction. If we can locate and finance properties meetingdo not close the Transaction, our criteria in locations desirableboard of directors will have to us. For more information concerning these risks, please see Part I, Sectionreexamine its plans with regard to acquiring real estate properties. See Item 1A - “Risk Factors” ofin our 20172018 Annual reportReport on Form 10-K, filed with the SEC on April 2, 2018.11, 2019.

In preparation for this new strategy, our management team is focused on repositioning the Company, both operationally and financially. As described in greater detail below, we have changed the name of the Company to identify with our new direction. In addition to seeking equity and debt financing, we have taken the actions described under “Recent Events” in our 2017 Annual report on Form 10-K to strengthen our balance sheet and pursue our new strategy.

10

Table of Contents

 

Critical Accounting Policies and Estimates

 

In response to the SEC's financial reporting release, FR-60, Cautionary Advice Regarding Disclosure About Critical Accounting Policies, the Company has selected its most subjective accounting estimation process for purposes of explaining the methodology used in calculating the estimate in addition to the inherent uncertainties pertaining to the estimate and the possible effects on the Company's financial condition.  These estimates involve certain assumptions that if incorrect could create a material adverse impact on the Company's results of operations and financial condition.  For a discussion of our significant accounting policies, See Note 5-4- "Summary of Significant Accounting Policies" in the accompanying Notes to Financial Statements.  

 

There were no material changes to our principal accounting estimates during the period covered by this report.    

12

Table of Contents

 

Results from Operations

 

The following table summarizes our results for the three and nine months ended September 30, 20182019 and 2017:2018:

 

  

Nine months ended September 30,

  

Variance

  

Three months ended September 30,

  

Variance

 
   2018   2017          2018   2017        
                               

General & administrative expenses

 $428,941  $368,331  $60,610  16.5% $133,399  $261,461  $(128,062) -49.0%

Loss from operations

  (428,941)  (368,331)  (60,610) 16.5%  (133,399)  (261,461)  128,062  -49.0%

Interest expense

  (1,024)  (16,618)  15,594  -93.8%  (256)  (1,230)  974  -79.2%

Net loss

 $(429,965) $(384,949) $(45,016) 11.7% $(133,655) $(262,691) $129,036  -49.1%
                               

Dividends for the benefit of preferred stockholders:

                              

Preferred stock dividends

 $(3,750) $(3,750) $-  0.0% $(1,250) $(1,250) $-  0.0%

Deemed dividends on preferred stock conversion

  -   (148,125)  148,125  N/A   -   -   -  N/A 

Net loss attributable to common stockholders

 $(433,715) $(536,824) $103,109  -19.3% $(134,905) $(263,941) $129,036  -48.9%

MedAmerica Properties Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

  

Nine months ended September 30,

  

Variance

  

Three months ended September 30,

  

Variance

 
  

2019

  

2018

  

$

  

%

  

2019

  

2018

  

 $

  

%

 
                                 

General & administrative expenses

 $272,894  $428,941  $(156,047)  -36.4% $9,034  $133,399  $(124,365)  -93.2%

Loss from operations

  (272,894)  (428,941)  156,047   -36.4%  (9,034)  (133,399)  124,365   -93.2%

Interest expense

  (1,313)  (1,024)  (289)  28.2%  (328)  (256)  (72)  28.1%

Net loss

 $(274,207) $(429,965) $155,758   -36.2% $(9,362) $(133,655) $124,293   -93.0%
                                 

Dividends for the benefit of preferred stockholders:

                                

Preferred stock dividends

  (3,750)  (3,750)  -   0.0%  (1,250)  (1,250)  -   0.0%

Net loss attributable to common stockholders

 $(277,957) $(433,715) $155,758   -35.9% $(10,612) $(134,905) $124,293   -92.1%
                                 
                                 

Basic and diluted average number of common shares outstanding

  2,610,568   2,610,568           2,610,568   2,610,568         
                                 

Net loss per common share basic and diluted

 $(0.11) $(0.17)         $(0.00) $(0.05)        

 

General and Administrative Expenses

 

General and administrative expenses include: compensation expense, professional fees, insurance, office and rent expenses and costs related to being a public company.

 

For the nine months ended September 30, 2018,2019, general and administrative expenses increased $60,610decreased $156,000 compared to the nine months ended September 30, 2017. The 2017 results included $117,756 of prior year expenses reimbursed by a related party in connection with the sale of BMP. The 2018 results included $125,078 of expenses reimbursed by a related party relative to the Company’s President and CEO.2018.

 

For the nine months ended September 30, 2018, net of2019, the expense reimbursementsoverall decrease in general and administrative expenses is primarily due to:

An increase in monthly cash amount received per the merger agreement of $75,000;

A decrease in rent of approximately $80,000 paid to a related party;

A decrease in private placement expenses of approximately $35,000;

A decrease in travel and entertainment of approximately $30,000;

A decrease in investors relations of approximately $14,000;

A decrease in computer expense of approximately $13,000;

A decrease in taxes of approximately $12,000;

A decrease in dues and subscriptions of approximately $6,000;

A decrease in other expenses of approximately $4,000;

A decrease in insurance of approximately $4,000;

A decrease in acquisition costs of approximately $3,000;

Offset by an increase in professional fees of approximately $90,000 and

An increase in officers’ compensation expense of approximately $30,000.

For the three months ended September 30, 2019, general and administrative expenses increased $124,000 compared to the three months ended September 30, 2018.

For the three months ended September 30, 2019, the overall increase in general and administrative expenses is primarily due to:

 

 

A decreaseAn increase in professional feesmonthly cash amount received per merger agreement of approximately $220,000 of which $24,000 is a reimbursement by a related party in 2018;$75,000;

 

A decrease in office and administration expenses of approximately $5,000;

Offset by an increase in acquisition costs of approximately $122,000 of which $118,000 is the reimbursement by a related party in 2017;

An increase in officers’ compensationprivate placement expense of approximately $40,000 of which $40,000 is a reimbursement by a related party in 2018;$22,000;

An increase in private placement of approximately $35,000;

An increase in rent of approximately $32,000 paid to a related party;

An increase in travel and entertainment of approximately $11,000 of which $62,000 is a reimbursement by a related party in 2018;

An increase in computer expense of approximately $10,000;

An increase in investors relations of approximately $10,000;

An increase in taxes of approximately $9,000;

An increase in insurance of approximately $8,000;

An increase in other expenses of approximately $8,000

For the three months ended September 30, 2018, general and administrative expenses decreased $128,062 compared to the three months ended September 30, 2017. The 2018 results included $13,211 of expenses reimbursed by a related party relative to services provided by the Company’s President and CEO.

For the three months ended September 30, 2018, net of the expense reimbursement in 2018 the overall increase in general and administrative expenses is primarily due to:

 

A decrease in professional feesrent of approximately $134,000 of which $3,000 is a reimbursement by$20,000 paid to a related party in 2018;party;

 

A decrease in travel and entertainment of approximately $12,000 of which $4,000 is a reimbursement by a related party in 2018;$8,000;

 

A decrease in rentdues and subscriptions of approximately $10,000 paid to a related party;$6,000

 

A decrease in office and administrationinsurance of approximately $4,000;

A decrease in computer expense of approximately $4,000;

A decrease in other expenses of approximately $2,000;

 

A decrease in investor relationstaxes of approximately $1,000;

 

Offset by an increase in private placementofficers’ compensation expense of approximately $23,000$12,000 and

 

An increaseincreased in insurancein professional fees of approximately $4,000

An increase in dues and subscriptions of approximately $3,000

An increase in taxes of approximately $1,000$6,000.

 

1113

Table of Contents

 

Interest expenseExpense

 

Interest expense was $1,024$1,313 and $16,618$1,024 for the nine months ended September 30, 20182019 and 2017,2018, respectively. Interest expense was $256$328 and $1,230$256 for the three months ended September 30, 20182019 and 2017,2018, respectively. The decreaseincrease in interest expense was due to the repayment of a related party note payableincrease in 2017.the rate charged for the insurance loan financing.

 

 

Income tax expenseTax Expense

 

Income tax expense was $0 for the three and nine months ended September 30, 20182019 and 20172018 due to a full valuation allowance being recorded by the Company for any deferred tax assets created as the result of any net operating losses generated by operations.

 

A valuation allowance is evaluated by considering all positive and negative evidence about whether the deferred tax assets will be realized. At the time of evaluation, the allowance can be either increased or reduced. A reduction could result in the complete elimination of the allowance if positive evidence indicates that the value of the deferred tax assets is no longer impaired and the allowance is no longer required.

 

 

Net loss attributableLoss Attributable to common shareholdersCommon Shareholders

 

Net loss attributable to common stockholders was $0.17($0.11) and $0.45($0.17) per share for the nine months ended September 30, 20182019 and 2017,2018, respectively. The difference of ($0.28)0.06) per common share is primarily the result of the monthly cash amount received in accordance with the merger agreement and a 2017 reimbursement of deal costs by a related party of approximately $118,000, the 2018 reimbursement of expenses by a related party of approximately $125,000, an increasedecrease in 2018 general and administrative expenses of $61,000 and an increase in weighted average shares outstanding.expenses.

 

Net loss attributable to commonscommon stockholders was $0.05($0.00) and $0.18($0.05) per share for the three months ended September 30, 20182019 and 2017,2018, respectively. The difference of ($0.13)0.05) per common share is primarily the result of a 2018 reimbursement of expenses by a related party of approximately $13,000, athe monthly cash amount received in accordance with the merger agreement and an decrease in 2018 general and administrative expenses of $128,000 and an increase in weighted average shares outstanding.expenses.

 

 

Financial Condition and Liquidity

 

Our cash balances at October 31, 2018,November 8, 2019, September 30, 20182019 and December 31, 20172018 were $237,815, $262,360$32,470, $32,233 and $708,382,$139,721, respectively. The following is a summary of our cash flow activity for the nine months ended September 30, 20182019 and 2017:2018:

 

  

Nine months ended September 30,

 
  

2018

  

2017

 

Net cash used in operating activities

 $(412,831) $(520,425)

Net cash provided by investing activities

 $-  $62,284 

Net cash (used in) provided by financing activities

 $(33,191) $1,609,595 

  

Nine months ended September 30,

 
  

2019

  

2018

 

Net cash used in operating activities

 $(74,304) $(412,831)

Net cash used in investing activities

 $-  $- 

Net cash used in financing activities

 $(33,184) $(33,191)

 

Net cashusedby in operating activities        

 

For the nine months ended September 30, 2018,2019, net cash used in operating activities was $412,831$74,304 as compared to $520,425$412,831 for the nine months ended September 30, 2017.2018. The decrease in cash used in operating activities was primarily due toa reduction in general and administrative expenses, the 2017monthly cash amount received in accordance with the merger agreement and 2018 reimbursement of costs by a related party, 2018 reductionan increase in accounts payable and accrued expenses and 2018 increase in net operating activities.expenses.

 

Net cash provided by investing activities

For the nine months ended September 30, 2018, net cash provided by investing activities was $0 as compared to $62,284 for the nine months ended September 30, 2017. The decrease in cash provided by investing activities was primarily due to the decrease in property deposits and an increase in acquisition of equipment and furnishings.

1214

Table of Contents

 

Net cash (used in) provided byused in financing activities

 in

For the nine months ended September 30, 2018,2019, net cash used in financing activities was $33,191$33,184 as compared to net cash provided byused in financing activities of $1,609,595$33,191 for the nine months ended September 30, 2017.2018. The decreaseincrease in net cash provided byused in financing activities was due primarily to the 2017 Private Placement which was launched on February 2017 and raised $1,803,665 (net of costs) through September 30, 2017. This was offset by a net decreaseincrease in the demand loan from a related party of approximately $194,070. The $33,191 used in financing activities during the nine months ended September 30, 2018 related to repayments of the note payable - insurance financing.

 

ThePending the closing of the Transaction, the Company recognizes that as a resultexpects to be able to borrow funds from an affiliate of its limited operations,Chairman in order to meet operating expenses. If the Transaction closes, the Company anticipates that it will continuehave adequate working capital and will not have to rely upon the sale of stock or capital contributions from investorsresort to generate cash flow and as we work towards generating positive cash from operating medical office buildings.

As of November 1, 2018, we had a cash balance of $237,815.   We believe that the cash on hand and access to the line of credit from a related party should meet our working capital needs for at leastloans. If the next 12 months.  However, as part of our business model seeking to acquire medical office buildings, we intend to seek to raise equity.  We cannot assure you that we will commence this task or that weclosing does not take place, the Company will be successful.reliant upon BEP unless it can obtain equity or debt financing from third parties.  BEP has committed to funding operations through April 2021in the event the Transaction does not close.

 

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable.

 

1315

Table of Contents

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934, as amended (the “Exchange Act”) Rule 13a-15(e)) as of September 30, 2018.2019.

 

Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective as of September 30, 2018.2019. 

 

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during the quarter ended September 30, 2018,2019, identified in connection with our evaluation that has materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

  

 

 

Part II - Other Information

 

Item 1. Legal Proceedings

 

The Company is not a party, nor is its property the subject of, any material pending legal proceedings.

 

.

Item 1A. Risk Factors

              There have been no material changes during the period covered by this report in the risk factors previously disclosed under "Risk Factors" in our 2018 Annual Report on Form 10-K.  

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

  

NoneNone.                               

Item 3. Defaults Upon Senior Securities

 

Not applicable.None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

1416

Table of Contents

 

Item 6. Exhibits

 

3.1 2.1

Restated CertificateAgreement and Plan of Incorporation,Merger, dated as of May 28, 2019, by and among Broad Street Realty , LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and Broad Street Realty Merger Sub LLC.  Exhibit 3.12.1 to the Registrant's Annual Report on Form 10-K for the fiscal year ended December8-K filed May 31, 2009 as filed April 15, 20102019 is incorporated by reference herein.

 

 

3.22.2

CertificateAgreement and Plan of AmendmentMerger, dated as of Certificate of Incorporation of B.H.I.T.May 28, 2019, by and among Broad Street Ventures, LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and Broad Street Ventures Merger Sub LLC.  Exhibit 3.12.2 to the Form 8-K filed January 6, 2010May 31, 2019 is incorporated by reference herein.

 

 

3.32.3

CertificateAgreement and Plan of Correction.Merger, dated as of May 28, 2019, by and among BSV Avondale LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Avondale Merger Sub LLC.  Exhibit 3.12.3 to the Form 8-K filed March 14, 2011May 31, 2019 is incorporated by reference herein.

 

 

3.42.4

CertificateAgreement and Plan of DesignationMerger, dated as of Series A Preferred Stock.May 28, 2019, by and among BSV Colonial Investors LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Colonial Merger Sub LLC.  Exhibit 3.12.4 to the Form 8-K dated February 5, 2010filed May 31, 2019 is incorporated by reference herein.

 

 

3.52.5

CertificateAgreement and Plan of Amendment to CertificateMerger, dated as of Incorporation ofMay 28, 2019, by and among BSV Coral Hills Investors LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Coral Hills Merger Sub LLC.  Exhibit 3.82.5 to the Form 10-K dated March 25, 20158-K filed May 31, 2019 is incorporated by reference herein.

 

 

3.62.6

CertificateAgreement and Plan of Amendment to CertificateMerger, dated as of Incorporation ofMay 28, 2019, by and among BSV Crestview Square LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Crestview Square Merger Sub LLC.  Exhibit 3.12.6 to the Form 8-K filed June 19, 2017May 31, 2019 is incorporated by reference herein.

 

 

3.72.7

AmendedAgreement and Restated BylawsPlan of the Registrant.Merger, dated as of May 28, 2019, by and among BSV Cromwell Parent LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Cromwell Merger Sub LLC.  Exhibit D2.7 to the Definitive Proxy StatementForm 8-K filed August 9, 2000May 31, 2019 is incorporated by reference herein.

 

 

2.8

Agreement and Plan of Merger, dated as of May 28, 2019, by and among BSV Cypress Point Investors LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Cypress Point Merger Sub LLC.  Exhibit 2.8 to the Form 8-K filed May 31, 2019 is incorporated by reference herein.

2.9

Agreement and Plan of Merger, dated as of May 28, 2019, by and among BSV Dekalb LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Dekalb Merger Sub LLC.  Exhibit 2.9 to the Form 8-K filed May 31, 2019 is incorporated by reference herein.

2.10

Agreement and Plan of Merger, dated as of May 28, 2019, by and among BSV Greenwood Investors LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Greenwood Merger Sub LLC.  Exhibit 2.10 to the Form 8-K filed May 31, 2019 is incorporated by reference herein.

2.11

Agreement and Plan of Merger, dated as of May 28, 2019, by and among BSV Highlandtown Investors LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Highlandtown Merger Sub LLC.  Exhibit 2.11 to the Form 8-K filed May 31, 2019 is incorporated by reference herein.

2.12

Agreement and Plan of Merger, dated as of May 28, 2019, by and among BSV Hollinswood LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Hollinswood Merger Sub LLC.  Exhibit 2.12 to the Form 8-K filed May 31, 2019 is incorporated by reference herein.

2.13

Agreement and Plan of Merger, dated as of May 28, 2019, by and among BSV Lamont Investors LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Lamont Merger Sub LLC.  Exhibit 2.13 to the Form 8-K filed May 31, 2019 is incorporated by reference herein.

2.14

Agreement and Plan of Merger, dated as of May 28, 2019, by and among BSV Lamonticello Investors LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Lamonticello Merger Sub LLC.  Exhibit 2.14 to the Form 8-K filed May 31, 2019 is incorporated by reference herein.

2.15

Agreement and Plan of Merger, dated as of May 28, 2019, by and among BSV LSP East Investors LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV LSP East Merger Sub LLC.  Exhibit 2.15 to the Form 8-K filed May 31, 2019 is incorporated by reference herein.

2.16

Agreement and Plan of Merger, dated as of May 28, 2019, by and among BSV Patrick Street Member LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Patrick Street Merger Sub LLC.  Exhibit 2.16 to the Form 8-K filed May 31, 2019 is incorporated by reference herein.

2.17

Agreement and Plan of Merger, dated as of May 28, 2019, by and among BSV Premier Brookhill LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Brookhill Merger Sub LLC.  Exhibit 2.17 to the Form 8-K filed May 31, 2019 is incorporated by reference herein.

2.18

Agreement and Plan of Merger, dated as of May 28, 2019, by and among BSV Spotswood Investors LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV Spotswood Merger Sub LLC.  Exhibit 2.18 to the Form 8-K filed May 31, 2019 is incorporated by reference herein.

2.19

Agreement and Plan of Merger, dated as of May 28, 2019, by and among BSV West Broad Investors LLC, MedAmerica Properties Inc., Broad Street Realty Operating Partnership, LP and BSV West Broad Merger Sub LLC.  Exhibit 2.19 to the Form 8-K filed May 31, 2019 is incorporated by reference herein.

10.1

Representation Warranty and Indemnification Agreement dated May 28, 2019, by and among, Michael Z. Jacoby, Thomas M. Yockey, MedAmerica Properties Inc. and Broad Street Operating Partnership, LP.  Exhibit 10.1 to the Form 8-K filed May 31, 2019 is incorporated herein.  

17

Table of Contents

31.1*

Rule 13a-14(a)13(a)-14(a)/15d-14(a)15(d-(14(a) Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

31.2*

Rule 13a-14(a)13(a)-14(a)/15d-14(a)15(d)-14(a) Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

32.1**

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

32.2**

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

101.INS*

XBRL Instance Document

 

 

101.SCH*

XBRL Schema Document

 

 

101.CAL*

XBRL Calculation Linkbase Document

 

 

101.DEF*

XBRL Definition Linkbase Document

 

 

101.LAB*

XBRL Label Linkbase Document

 

 

101.PRE*

XBRL Presentation Linkbase Document

 

*Filed herewith

**Furnished herewith

 

1518

Table of Contents

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

MedAmerica Properties Inc.

 

 

Date: November 13, 201812, 2019

By:

/s/ Joseph C. Bencivenga

 

 

Joseph C. Bencivenga

President and Chief Executive Officer

(Principal Executive Officer)

 

 

 

Date:  November 13, 201812, 2019

By:

/s/ Patricia K. Sheridan

 

 

Patricia K. Sheridan

Chief Financial Officer

(Principal Financial Officer)

 

19

16